All stock lists
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.05+1.34 (+36.12%)
Market cap
$13.3M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 27, 2018
Website
Insider Score
––Not scored
ADIL Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ADIL analyst forecast
Best analysts covering ADIL
No firm covering ADIL has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ADIL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Maxim Group | Buy | — | — | Upgraded | 2025-09-30 |
| — | Brookline Capital | Buy | — | — | Reiterated | 2023-07-11 |
| — | Maxim Group | Hold | — | — | Downgraded | 2022-08-17 |
| — | Brookline Capital | Buy | — | — | Reiterated | 2021-10-13 |
| — | Litchfield Hills | Buy | — | — | Reiterated | 2021-06-29 |
ADIL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-13 | -2.25 | -2.00 | $0 | $0 |
| 2026-03-10 | -2.10 | -1.81 | $0 | $0 |
| 2026-05-13 | -2.73 | -1.48 | $0 | $0 |
| 2026-08-12 | -1.03 | -11.25 | $0 | $0 |
| 2026-11-18Upcoming | -0.17 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.